Early-onset and later-onset cancer: trends, risk factors, and prevention in Northern China

The characteristics of early-onset (onset age <50 years) and later-onset (onset age ≽ 50 years) cancers differ significantly. Identifying novel risk factors for both types of cancer is crucial for increasing awareness of cancer prevention and for reducing its burden. This study aimed to analyze t...

Full description

Saved in:
Bibliographic Details
Published inScience China. Life sciences Vol. 67; no. 9; pp. 1928 - 1940
Main Authors Liu, Tong, Liu, Chen-An, Zhang, Qing-Song, Zhang, Qi, Wang, Yi-Ming, Song, Meng-Meng, Lin, Shi-Qi, Deng, Li, Wu, Shou-Ling, Shi, Han-Ping
Format Journal Article
LanguageEnglish
Published Beijing Science China Press 01.09.2024
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The characteristics of early-onset (onset age <50 years) and later-onset (onset age ≽ 50 years) cancers differ significantly. Identifying novel risk factors for both types of cancer is crucial for increasing awareness of cancer prevention and for reducing its burden. This study aimed to analyze the trends in incidence and risk factors for early-onset and late-onset cancers. We conducted a prospective study by drawing data from the Kailuan Study. This study included 6,741 participants with cancer (624 with early-onset cancer and 6,117 with later-onset cancer) and 6,780 matched controls among the 186,249 participants who underwent Kailuan health examinations from 2006 to 2019. The primary outcomes were cancer incidence rates, and associated risk factors for early- and later-onset cancer. Weighted Cox regression was used to calculate hazard ratios and 95% confidence intervals of each exposure factor for early- and later-onset cancer by cancer type. Population-attributable risk proportions were used to estimate the number of cases that could be prevented by eliminating a risk factor from the population. Except for liver cancer, incidence rates for nearly all types of cancer increased during the study period. Smoking, alcohol consumption, lipid metabolism disorders, hypertension, diabetes mellitus, fatty liver, and inflammation were associated with a significantly increased risk of cancer at multiple sites, but risk factors for cancer incidence differed by site. Smoking, alcohol consumption, inflammation, and hypertension were the major contributors to preventable cancer. The incidence of several different types of cancer, including early-onset cancer, is increasing in northeastern China. Differences in risk factors between early-onset and later-onset malignancies may contribute to the divergence in the observed changes in incidence trends between these two specific types of cancer.
AbstractList The characteristics of early-onset (onset age <50 years) and later-onset (onset age ≽ 50 years) cancers differ significantly. Identifying novel risk factors for both types of cancer is crucial for increasing awareness of cancer prevention and for reducing its burden. This study aimed to analyze the trends in incidence and risk factors for early-onset and late-onset cancers. We conducted a prospective study by drawing data from the Kailuan Study. This study included 6,741 participants with cancer (624 with early-onset cancer and 6,117 with later-onset cancer) and 6,780 matched controls among the 186,249 participants who underwent Kailuan health examinations from 2006 to 2019. The primary outcomes were cancer incidence rates, and associated risk factors for early- and later-onset cancer. Weighted Cox regression was used to calculate hazard ratios and 95% confidence intervals of each exposure factor for early- and later-onset cancer by cancer type. Population-attributable risk proportions were used to estimate the number of cases that could be prevented by eliminating a risk factor from the population. Except for liver cancer, incidence rates for nearly all types of cancer increased during the study period. Smoking, alcohol consumption, lipid metabolism disorders, hypertension, diabetes mellitus, fatty liver, and inflammation were associated with a significantly increased risk of cancer at multiple sites, but risk factors for cancer incidence differed by site. Smoking, alcohol consumption, inflammation, and hypertension were the major contributors to preventable cancer. The incidence of several different types of cancer, including early-onset cancer, is increasing in northeastern China. Differences in risk factors between early-onset and later-onset malignancies may contribute to the divergence in the observed changes in incidence trends between these two specific types of cancer.The characteristics of early-onset (onset age <50 years) and later-onset (onset age ≽ 50 years) cancers differ significantly. Identifying novel risk factors for both types of cancer is crucial for increasing awareness of cancer prevention and for reducing its burden. This study aimed to analyze the trends in incidence and risk factors for early-onset and late-onset cancers. We conducted a prospective study by drawing data from the Kailuan Study. This study included 6,741 participants with cancer (624 with early-onset cancer and 6,117 with later-onset cancer) and 6,780 matched controls among the 186,249 participants who underwent Kailuan health examinations from 2006 to 2019. The primary outcomes were cancer incidence rates, and associated risk factors for early- and later-onset cancer. Weighted Cox regression was used to calculate hazard ratios and 95% confidence intervals of each exposure factor for early- and later-onset cancer by cancer type. Population-attributable risk proportions were used to estimate the number of cases that could be prevented by eliminating a risk factor from the population. Except for liver cancer, incidence rates for nearly all types of cancer increased during the study period. Smoking, alcohol consumption, lipid metabolism disorders, hypertension, diabetes mellitus, fatty liver, and inflammation were associated with a significantly increased risk of cancer at multiple sites, but risk factors for cancer incidence differed by site. Smoking, alcohol consumption, inflammation, and hypertension were the major contributors to preventable cancer. The incidence of several different types of cancer, including early-onset cancer, is increasing in northeastern China. Differences in risk factors between early-onset and later-onset malignancies may contribute to the divergence in the observed changes in incidence trends between these two specific types of cancer.
The characteristics of early-onset (onset age <50 years) and later-onset (onset age ≽ 50 years) cancers differ significantly. Identifying novel risk factors for both types of cancer is crucial for increasing awareness of cancer prevention and for reducing its burden. This study aimed to analyze the trends in incidence and risk factors for early-onset and late-onset cancers. We conducted a prospective study by drawing data from the Kailuan Study. This study included 6,741 participants with cancer (624 with early-onset cancer and 6,117 with later-onset cancer) and 6,780 matched controls among the 186,249 participants who underwent Kailuan health examinations from 2006 to 2019. The primary outcomes were cancer incidence rates, and associated risk factors for early- and later-onset cancer. Weighted Cox regression was used to calculate hazard ratios and 95% confidence intervals of each exposure factor for early- and later-onset cancer by cancer type. Population-attributable risk proportions were used to estimate the number of cases that could be prevented by eliminating a risk factor from the population. Except for liver cancer, incidence rates for nearly all types of cancer increased during the study period. Smoking, alcohol consumption, lipid metabolism disorders, hypertension, diabetes mellitus, fatty liver, and inflammation were associated with a significantly increased risk of cancer at multiple sites, but risk factors for cancer incidence differed by site. Smoking, alcohol consumption, inflammation, and hypertension were the major contributors to preventable cancer. The incidence of several different types of cancer, including early-onset cancer, is increasing in northeastern China. Differences in risk factors between early-onset and later-onset malignancies may contribute to the divergence in the observed changes in incidence trends between these two specific types of cancer.
Author Deng, Li
Wu, Shou-Ling
Zhang, Qi
Liu, Tong
Lin, Shi-Qi
Shi, Han-Ping
Song, Meng-Meng
Wang, Yi-Ming
Zhang, Qing-Song
Liu, Chen-An
Author_xml – sequence: 1
  givenname: Tong
  surname: Liu
  fullname: Liu, Tong
  organization: Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Key Laboratory of Cancer FSMP for State Market Regulation, Laboratory for Clinical Medicine, Capital Medical University
– sequence: 2
  givenname: Chen-An
  surname: Liu
  fullname: Liu, Chen-An
  organization: Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Key Laboratory of Cancer FSMP for State Market Regulation, Laboratory for Clinical Medicine, Capital Medical University
– sequence: 3
  givenname: Qing-Song
  surname: Zhang
  fullname: Zhang, Qing-Song
  organization: Department of General Surgery, Kailuan General Hospital
– sequence: 4
  givenname: Qi
  surname: Zhang
  fullname: Zhang, Qi
  organization: Department of Genetics, Yale School of Medicine
– sequence: 5
  givenname: Yi-Ming
  surname: Wang
  fullname: Wang, Yi-Ming
  organization: Department of Hepatobiliary Surgery, Kailuan General Hospital
– sequence: 6
  givenname: Meng-Meng
  surname: Song
  fullname: Song, Meng-Meng
  organization: Cardiovascular Research Institute, University of California
– sequence: 7
  givenname: Shi-Qi
  surname: Lin
  fullname: Lin, Shi-Qi
  organization: Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Key Laboratory of Cancer FSMP for State Market Regulation, Laboratory for Clinical Medicine, Capital Medical University
– sequence: 8
  givenname: Li
  surname: Deng
  fullname: Deng, Li
  email: dengli070@foxmail.com
  organization: Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Key Laboratory of Cancer FSMP for State Market Regulation, Laboratory for Clinical Medicine, Capital Medical University
– sequence: 9
  givenname: Shou-Ling
  surname: Wu
  fullname: Wu, Shou-Ling
  email: drwusl@163.com
  organization: Department of Cardiology, Kailuan General Hospital
– sequence: 10
  givenname: Han-Ping
  surname: Shi
  fullname: Shi, Han-Ping
  email: shihp@ccmu.edu.cn
  organization: Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Key Laboratory of Cancer FSMP for State Market Regulation, Laboratory for Clinical Medicine, Capital Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38809499$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1vFDEMhiPUipbSH8AFjcSFA1OcZPLFrVqVD6kqF7hwiTJJhk6ZTRYni9R_T1a7FVIlmoNjW89rWX5fkKOUUyTkFYULCqDeF0oHpnpgvGeiBfGMnFItTU-1Nkctl2roFQdxQs5LuYP2OAem1HNywrUGMxhzSn5cOVzu-5xKrJ1LoVtcjXiovUs-4oeuYkyhvOtwLr-6yfmasVU7eoPxT0x1zqmbU3eTsd5GTN3qdk7uJTme3FLi-eE_I98_Xn1bfe6vv376srq87j1XrPZ-ApgCBGO4chPzzmsKWjKjQhgGEUYueEtGGDSMQYOYdAAqtRBy9K3Fz8jb_dwN5t_bWKpdz8XHZXEp5m2xHCRVehhAN_TNI_QubzG17RpllGZaStmo1wdqO65jsBuc1w7v7cPVGqD2gMdcCsbJ-rm63RUqunmxFOzOIru3yDaL7M4iK5qSPlI-DH9Kw_aa0tj0M-K_pf8v-gurfaC0
CitedBy_id crossref_primary_10_1007_s11427_024_2622_1
crossref_primary_10_5306_wjco_v15_i10_1269
crossref_primary_10_1007_s11427_024_2810_y
crossref_primary_10_1016_j_tranon_2025_102341
Cites_doi 10.1016/j.atherosclerosis.2016.02.006
10.3748/wjg.v21.i17.5167
10.1016/S2468-2667(18)30267-6
10.1016/S1470-2045(12)70211-5
10.1016/S0140-6736(05)67725-2
10.1002/cncr.29685
10.1007/s11427-023-2343-y
10.3748/wjg.v26.i44.7061
10.1200/JCO.2016.70.5327
10.1136/gutjnl-2019-319511
10.1016/j.suronc.2015.02.002
10.1159/000445054
10.1016/S0140-6736(18)32225-6
10.1016/S2214-109X(20)30215-1
10.3390/cancers14164021
10.1093/jnci/djk181
10.1111/liv.15195
10.1016/j.coph.2012.07.006
10.1007/s11427-023-2422-x
10.1016/S2468-2667(22)00227-4
10.1093/jnci/djaa007
10.1097/CEJ.0b013e328330eb1a
10.21147/j.issn.1000-9604.2020.02.01
10.1007/s11427-023-2423-1
10.3322/caac.21338
10.3945/ajcn.111.031419
10.1016/j.eururo.2015.08.037
10.1002/cac2.12197
10.1016/j.dsx.2023.102896
10.1002/cnr2.1109
10.1007/s11427-022-2340-4
10.1038/s41571-022-00672-8
10.1038/srep31358
10.1016/j.metabol.2018.11.001
10.1007/s00125-020-05338-7
10.2471/BLT.18.219469
10.1038/s41571-020-00445-1
10.3322/caac.21440
10.3390/cancers14133277
10.1200/JCO.2015.65.5845
10.1002/ijc.29223
10.1016/S1470-2045(14)70263-3
10.1038/537S103a
10.1111/1753-6405.12471
10.1161/CIRCULATIONAHA.111.065904
10.1007/s11427-022-2104-3
10.1002/cncr.33916
10.1016/S1470-2045(20)30398-3
10.1007/s10654-019-00530-5
10.1200/JCO.2010.31.5200
10.3322/caac.21763
10.1038/nature01322
10.1186/s12944-018-0768-7
10.1016/S1470-2045(17)30677-0
10.1016/j.celrep.2013.10.006
10.1016/j.medici.2016.03.002
10.1371/journal.pone.0095197
10.1007/s00011-022-01597-9
10.1038/s41416-018-0029-6
10.1038/sj.bjc.6603386
10.1158/2159-8290.CD-22-1038
10.1093/jnci/djw322
ContentType Journal Article
Copyright Science China Press 2024
2024. Science China Press.
Science China Press 2024.
Copyright_xml – notice: Science China Press 2024
– notice: 2024. Science China Press.
– notice: Science China Press 2024.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
7U9
H94
K9.
7X8
DOI 10.1007/s11427-023-2523-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Virology and AIDS Abstracts
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1869-1889
EndPage 1940
ExternalDocumentID 38809499
10_1007_s11427_023_2523_5
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
-A0
-EM
-SA
-S~
-Y2
0R~
1N0
2B.
2C.
2VQ
3V.
4.4
406
40D
40G
53G
5VR
5VS
7X7
88A
88E
8AO
8FE
8FH
8FI
8FJ
8TC
92E
92I
92Q
93N
AAAVM
AACDK
AAHNG
AAIAL
AAJBT
AANXM
AANZL
AARHV
AASML
AATNV
AATVU
AAUYE
AAXDM
AAYQN
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABJNI
ABJOX
ABKCH
ABMQK
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABUWG
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACIHN
ACOKC
ACPIV
ACPRK
ACREN
ACZOJ
ADINQ
ADKNI
ADKPE
ADRFC
ADURQ
ADYFF
ADZKW
AEAQA
AEFQL
AEJRE
AEMSY
AEOHA
AEPYU
AESKC
AEVLU
AEXYK
AFKRA
AFLOW
AFQWF
AFUIB
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AHBYD
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AILAN
AITGF
AJRNO
AJZVZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AMXSW
AMYLF
AXYYD
BBNVY
BENPR
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
C6C
CAG
CAJEA
CCEZO
CCPQU
CCVFK
CJPJV
COF
CSCUP
DIK
DNIVK
DPUIP
EBLON
EBS
EIOEI
EJD
EMOBN
F5P
FA0
FERAY
FIGPU
FINBP
FNLPD
FSGXE
FYUFA
GGCAI
GJIRD
GX1
H13
H4N
HCIFZ
HG6
HMCUK
HZ~
IKXTQ
IWAJR
J-C
JZLTJ
KOV
KQ8
LK8
LLZTM
M0L
M1P
M4Y
M7P
NPVJJ
NQJWS
NU0
O9J
OK1
PQQKQ
PROAC
PSQYO
PT4
Q--
Q2X
RIG
RNS
ROL
RSV
SBL
SCL
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SV3
TCJ
TGP
TR2
TSG
U1G
U2A
U5K
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VFIZW
WK8
Z7U
ZMTXR
AAYXX
ABBRH
ABDBE
ACMFV
AFDZB
AFOHR
AHPBZ
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7QP
7TK
7U9
H94
K9.
7X8
ID FETCH-LOGICAL-c372t-cf00fd0d9937af2cac81086297dd445db353d44b0480bd805f8d0168556bc80b3
IEDL.DBID 40G
ISSN 1674-7305
1869-1889
IngestDate Fri Jul 11 08:40:20 EDT 2025
Wed Aug 13 09:49:07 EDT 2025
Fri Aug 15 02:01:13 EDT 2025
Tue Jul 01 03:56:27 EDT 2025
Thu Apr 24 22:58:31 EDT 2025
Fri Feb 21 02:39:53 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords cancer
later-onset
early-onset
trend
risk factor
prevention
Language English
License 2024. Science China Press.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c372t-cf00fd0d9937af2cac81086297dd445db353d44b0480bd805f8d0168556bc80b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 38809499
PQID 3097828666
PQPubID 54335
PageCount 13
ParticipantIDs proquest_miscellaneous_3061784408
proquest_journals_3097828666
pubmed_primary_38809499
crossref_citationtrail_10_1007_s11427_023_2523_5
crossref_primary_10_1007_s11427_023_2523_5
springer_journals_10_1007_s11427_023_2523_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-09-01
PublicationDateYYYYMMDD 2024-09-01
PublicationDate_xml – month: 09
  year: 2024
  text: 2024-09-01
  day: 01
PublicationDecade 2020
PublicationPlace Beijing
PublicationPlace_xml – name: Beijing
– name: China
PublicationTitle Science China. Life sciences
PublicationTitleAbbrev Sci. China Life Sci
PublicationTitleAlternate Sci China Life Sci
PublicationYear 2024
Publisher Science China Press
Springer Nature B.V
Publisher_xml – name: Science China Press
– name: Springer Nature B.V
References Sung, Siegel, Rosenberg, Jemal (CR58) 2019; 4
Wu, Ishikawa, Sirianni, Tang, McDonald, Yuhanna, Thompson, Girard, Mineo, Brekken (CR62) 2013; 5
Emspak (CR24) 2016; 537
Diakos, Charles, McMillan, Clarke (CR20) 2014; 15
Avgerinos, Spyrou, Mantzoros, Dalamaga (CR3) 2019; 92
Duffy, Vulkan, Cuckle, Parmar, Sheikh, Smith, Evans, Blyuss, Johns, Ellis (CR23) 2020; 21
Dobruch, Daneshmand, Fisch, Lotan, Noon, Resnick, Shariat, Zlotta, Boorjian (CR22) 2016; 69
Kim, Paik, Yoon, Lee, Kim, Sung (CR35) 2015; 21
Whiteman, Webb, Green, Neale, Fritschi, Bain, Parkin, Wilson, Olsen, Nagle (CR61) 2015; 39
(CR16) 2018; 392
Gong, Cheng, Yang, Shen, Zhu, Ling, Lin, Yu, Li, Tan (CR26) 2022; 65
Nechuta, Shu, Li, Yang, Ji, Xiang, Cai, Chow, Gao, Zheng (CR46) 2012; 96
Fidler, Gupta, Soerjomataram, Ferlay, Steliarova-Foucher, Bray (CR25) 2017; 18
Ben-Aharon, van Laarhoven, Fontana, Obermannova, Nilsson, Lordick (CR5) 2023; 13
Bray, Jemal, Grey, Ferlay, Forman (CR7) 2012; 13
Liu, Liang, Jing, Liu (CR42) 2019; 97
Lee, DuBois, Coccia, Bleyer, Olin, Goldsby (CR38) 2016; 122
Li, Yu, Guo, Bian, Shen, Yang, Chen, Wei, Zhang, Qiu (CR40) 2019; 34
Radišauskas, Kuzmickienė, Milinavičienė, Everatt (CR50) 2016; 52
Ding, Zhang, Li, Yang (CR21) 2019; 9
Arnoldi, De Lorenzo, Mano, Schraner, Wild, Eichwald, Burrone (CR2) 2014; 9
Lee, Hunter, Spiegelman, Adami, Albanes, Bernstein, van den Brandt, Buring, Cho, Folsom (CR37) 2007; 99
Bansal (CR4) 2018; 1
He, Xia, Li, Cao, Yang, Yan, Zhang, Teng, Li, Chen (CR31) 2024; 67
Xue, Lyu (CR63) 2024; 67
Björkström, Widman, Hagström (CR6) 2022; 42
Cassidy, Myles, Duffy, Liloglou, Field (CR10) 2006; 95
Liu, Liu, Zhang, Zhang, Wang, Song, Lin, Deng, Wu, Shi (CR44) 2023; 17
Siegel, Torre, Soerjomataram, Hayes, Bray, Weber, Jemal (CR56) 2019; 68
Hamilton, Donnelly, Fitzpatrick, Coleman (CR30) 2022; 14
Chao, Xu, Bhatia, Cooper, Brar, Wong, Armenian (CR12) 2016; 34
Chen, Zheng, Baade, Zhang, Zeng, Bray, Jemal, Yu, He (CR14) 2016; 66
Qiu, Cao, Xu (CR49) 2021; 41
Rotondi, Castagna, Cappelli, Ciuoli, Coperchini, Chiofalo, Maino, Palmitesta, Chiovato, Pacini (CR51) 2016; 5
Sanikini, Dik, Siersema, Bhoo-Pathy, Uiterwaal, Peeters, González, Zamora-Ros, Overvad, Tjønneland (CR52) 2015; 136
Deandrea, Foschi, Galeone, La Vecchia, Negri, Hu (CR19) 2010; 19
Ugai, Sasamoto, Lee, Ando, Song, Tamimi, Kawachi, Campbell, Giovannucci, Weiderpass (CR59) 2022; 19
Liang, Xie, Li, Wang, Wang, Meng, Ji, Zhu, Xu, Zheng (CR41) 2016; 6
CR54
Akimoto, Ugai, Zhong, Hamada, Fujiyoshi, Giannakis, Wu, Cao, Ng, Ogino (CR1) 2021; 18
Siegel, Miller, Wagle, Jemal (CR55) 2023; 73
Brown, Rumgay, Dunlop, Ryan, Quartly, Cox, Deas, Elliss-Brookes, Gavin, Hounsome (CR8) 2018; 118
Kitahara, Berrington de González, Freedman, Huxley, Mok, Jee, Samet (CR36) 2011; 29
Wang, Duan, Yang (CR60) 2015; 24
Islami, Goding Sauer, Miller, Siegel, Fedewa, Jacobs, McCullough, Patel, Ma, Soerjomataram (CR34) 2018; 68
Yang, Xiao, Yang, Ji, Jia, Weng, Lu, Shan, Liu, Tian (CR64) 2012; 125
Heer, Harper, Escandor, Sung, McCormack, Fidler-Benaoudia (CR32) 2020; 8
Pelton, Freeman, Solomon (CR48) 2012; 12
Huang, Huang, Mi, Lin, He, Lu, Yue, Bai, Zhang, Zhang (CR33) 2020; 26
Liu, Fan, Zhang, Wang, Yao, Song, Zhang, Cao, Song, Shi (CR43) 2022; 71
Shah, Millien, da Costa, Oluyomi, Gould Suarez, Thrift (CR53) 2022; 128
Danaei, Vander Hoorn, Lopez, Murray, Ezzati (CR18) 2005; 366
Chen, Sun, Gu, Ai, Yang, Zhang, Hou, Wang, Ou, Jiang (CR13) 2023; 66
Coussens, Werb (CR17) 2002; 420
Gong, Cheung, Read, Na, Lega, Lipscombe (CR27) 2021; 64
Chan, Wright, Xiao, Guo, Chen, Du, Yang, Millwood, Pei, Wang (CR11) 2022; 7
Li, Lu, Fu, Wan, Wang, Huo, Xu, Xu, Zhao, Chen (CR39) 2020; 10
Goodwin, Chlebowski (CR28) 2016; 34
Pan, Yang, Wu, Yin, Liao, Wang, Gao, Zhang (CR47) 2016; 248
Liu, Yu, Mao, Li, Zhang, Yang, Zhang, Liu, Qian, Li (CR45) 2018; 17
Cai, Xu, Saw (CR9) 2024; 67
Sun, Cao, Li, He, Chen (CR57) 2020; 32
Choi, Cheong, Lee, Kang, Lee, Oh, Eun (CR15) 2022; 14
Gupta, Harper, Ruan, Barr, Frazier, Ferlay, Steliarova-Foucher, Fidler-Benaoudia (CR29) 2020; 112
C Chao (2523_CR12) 2016; 34
CM Kitahara (2523_CR36) 2011; 29
RL Siegel (2523_CR56) 2019; 68
N Akimoto (2523_CR1) 2021; 18
MM Fidler (2523_CR25) 2017; 18
Y Wang (2523_CR60) 2015; 24
Collaborators, G.R.F. (2523_CR16) 2018; 392
X Liu (2523_CR45) 2018; 17
J Liu (2523_CR42) 2019; 97
C Gong (2523_CR26) 2022; 65
PJ Goodwin (2523_CR28) 2016; 34
H Qiu (2523_CR49) 2021; 41
W Chen (2523_CR14) 2016; 66
KI Avgerinos (2523_CR3) 2019; 92
SE Kim (2523_CR35) 2015; 21
KH Chan (2523_CR11) 2022; 7
IY Gong (2523_CR27) 2021; 64
DC Whiteman (2523_CR61) 2015; 39
J Dobruch (2523_CR22) 2016; 69
S Deandrea (2523_CR19) 2010; 19
RL Siegel (2523_CR55) 2023; 73
Q Wu (2523_CR62) 2013; 5
S He (2523_CR31) 2024; 67
T Ugai (2523_CR59) 2022; 19
M Li (2523_CR39) 2020; 10
2523_CR54
Z Liang (2523_CR41) 2016; 6
R Radišauskas (2523_CR50) 2016; 52
G Chen (2523_CR13) 2023; 66
SW Duffy (2523_CR23) 2020; 21
LM Coussens (2523_CR17) 2002; 420
J Emspak (2523_CR24) 2016; 537
L Pan (2523_CR47) 2016; 248
F Islami (2523_CR34) 2018; 68
X Ding (2523_CR21) 2019; 9
T Liu (2523_CR44) 2023; 17
N Bansal (2523_CR4) 2018; 1
J Cai (2523_CR9) 2024; 67
W Yang (2523_CR64) 2012; 125
I Ben-Aharon (2523_CR5) 2023; 13
CF Huang (2523_CR33) 2020; 26
E Heer (2523_CR32) 2020; 8
A Cassidy (2523_CR10) 2006; 95
S Gupta (2523_CR29) 2020; 112
JS Lee (2523_CR38) 2016; 122
K Pelton (2523_CR48) 2012; 12
T Liu (2523_CR43) 2022; 71
RR Shah (2523_CR53) 2022; 128
M Rotondi (2523_CR51) 2016; 5
K Björkström (2523_CR6) 2022; 42
AC Hamilton (2523_CR30) 2022; 14
S Nechuta (2523_CR46) 2012; 96
F Bray (2523_CR7) 2012; 13
D Sun (2523_CR57) 2020; 32
SY Choi (2523_CR15) 2022; 14
X Li (2523_CR40) 2019; 34
J Xue (2523_CR63) 2024; 67
CI Diakos (2523_CR20) 2014; 15
H Sanikini (2523_CR52) 2015; 136
JE Lee (2523_CR37) 2007; 99
F Arnoldi (2523_CR2) 2014; 9
G Danaei (2523_CR18) 2005; 366
KF Brown (2523_CR8) 2018; 118
H Sung (2523_CR58) 2019; 4
References_xml – volume: 248
  start-page: 2
  year: 2016
  end-page: 9
  ident: CR47
  article-title: The prevalence, awareness, treatment and control of dyslipidemia among adults in China
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2016.02.006
– volume: 21
  start-page: 5167
  year: 2015
  end-page: 5175
  ident: CR35
  article-title: Sex- and gender-specific disparities in colorectal cancer risk
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v21.i17.5167
– volume: 4
  start-page: e137
  year: 2019
  end-page: e147
  ident: CR58
  article-title: Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry
  publication-title: Lancet Public Health
  doi: 10.1016/S2468-2667(18)30267-6
– volume: 13
  start-page: 790
  year: 2012
  end-page: 801
  ident: CR7
  article-title: Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(12)70211-5
– volume: 366
  start-page: 1784
  year: 2005
  end-page: 1793
  ident: CR18
  article-title: Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67725-2
– volume: 122
  start-page: 116
  year: 2016
  end-page: 123
  ident: CR38
  article-title: Increased risk of second malignant neoplasms in adolescents and young adults with cancer
  publication-title: Cancer
  doi: 10.1002/cncr.29685
– volume: 66
  start-page: 2805
  year: 2023
  end-page: 2817
  ident: CR13
  article-title: FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway
  publication-title: Sci China Life Sci
  doi: 10.1007/s11427-023-2343-y
– volume: 26
  start-page: 7061
  year: 2020
  end-page: 7075
  ident: CR33
  article-title: Associations between serum uric acid and hepatobiliary-pancreatic cancer: a cohort study
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v26.i44.7061
– volume: 34
  start-page: 4197
  year: 2016
  end-page: 4202
  ident: CR28
  article-title: Obesity and cancer: insights for clinicians
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2016.70.5327
– volume: 68
  start-page: 2179
  year: 2019
  end-page: 2185
  ident: CR56
  article-title: Global patterns and trends in colorectal cancer incidence in young adults
  publication-title: Gut
  doi: 10.1136/gutjnl-2019-319511
– volume: 24
  start-page: 67
  year: 2015
  end-page: 70
  ident: CR60
  article-title: A case-control study of stomach cancer in relation to in China
  publication-title: Surg Oncol
  doi: 10.1016/j.suronc.2015.02.002
– volume: 5
  start-page: 125
  year: 2016
  end-page: 131
  ident: CR51
  article-title: Obesity does not modify the risk of differentiated thyroid cancer in a cytological series of thyroid nodules
  publication-title: Eur Thyroid J
  doi: 10.1159/000445054
– ident: CR54
– volume: 9
  start-page: 219
  year: 2019
  end-page: 227
  ident: CR21
  article-title: The role of cholesterol metabolism in cancer
  publication-title: Am J Cancer Res
– volume: 392
  start-page: 1923
  year: 2018
  end-page: 1994
  ident: CR16
  article-title: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)32225-6
– volume: 8
  start-page: e1027
  year: 2020
  end-page: e1037
  ident: CR32
  article-title: Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(20)30215-1
– volume: 14
  start-page: 4021
  year: 2022
  ident: CR30
  article-title: Early-onset cancers in adults: a review of epidemiology, supportive care needs and future research priorities
  publication-title: Cancers
  doi: 10.3390/cancers14164021
– volume: 99
  start-page: 801
  year: 2007
  end-page: 810
  ident: CR37
  article-title: Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djk181
– volume: 42
  start-page: 820
  year: 2022
  end-page: 828
  ident: CR6
  article-title: Risk of hepatic and extrahepatic cancer in NAFLD: a population-based cohort study
  publication-title: Liver Int
  doi: 10.1111/liv.15195
– volume: 12
  start-page: 751
  year: 2012
  end-page: 759
  ident: CR48
  article-title: Cholesterol and prostate cancer
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2012.07.006
– volume: 67
  start-page: 274
  year: 2024
  end-page: 285
  ident: CR63
  article-title: Challenges and opportunities in rare cancer research in China
  publication-title: Sci China Life Sci
  doi: 10.1007/s11427-023-2422-x
– volume: 7
  start-page: e1014
  year: 2022
  end-page: e1026
  ident: CR11
  article-title: Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study
  publication-title: Lancet Public Health
  doi: 10.1016/S2468-2667(22)00227-4
– volume: 112
  start-page: 1105
  year: 2020
  end-page: 1117
  ident: CR29
  article-title: International trends in the incidence of cancer among adolescents and young adults
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djaa007
– volume: 19
  start-page: 18
  year: 2010
  end-page: 22
  ident: CR19
  article-title: Is temperature an effect modifier of the association between green tea intake and gastric cancer risk?
  publication-title: Eur J Cancer Prev
  doi: 10.1097/CEJ.0b013e328330eb1a
– volume: 32
  start-page: 129
  year: 2020
  end-page: 139
  ident: CR57
  article-title: Cancer burden and trends in China: a review and comparison with Japan and South Korea
  publication-title: Chin J Cancer Res
  doi: 10.21147/j.issn.1000-9604.2020.02.01
– volume: 67
  start-page: 122
  year: 2024
  end-page: 131
  ident: CR31
  article-title: Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors
  publication-title: Sci China Life Sci
  doi: 10.1007/s11427-023-2423-1
– volume: 66
  start-page: 115
  year: 2016
  end-page: 132
  ident: CR14
  article-title: Cancer statistics in China, 2015
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21338
– volume: 96
  start-page: 1056
  year: 2012
  end-page: 1063
  ident: CR46
  article-title: Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women’s Health Study
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.111.031419
– volume: 69
  start-page: 300
  year: 2016
  end-page: 310
  ident: CR22
  article-title: Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2015.08.037
– volume: 41
  start-page: 1037
  year: 2021
  end-page: 1048
  ident: CR49
  article-title: Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020
  publication-title: Cancer Commun
  doi: 10.1002/cac2.12197
– volume: 17
  start-page: 102896
  year: 2023
  ident: CR44
  article-title: Association of the age of onset of metabolic syndrome with the risk of all cancer types
  publication-title: Diabetes Metab Syndr
  doi: 10.1016/j.dsx.2023.102896
– volume: 1
  start-page: e1109
  year: 2018
  ident: CR4
  article-title: Introducing —the concept, execution and vision
  publication-title: Cancer Rep
  doi: 10.1002/cnr2.1109
– volume: 67
  start-page: 19
  year: 2024
  end-page: 40
  ident: CR9
  article-title: Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance
  publication-title: Sci China Life Sci
  doi: 10.1007/s11427-022-2340-4
– volume: 19
  start-page: 656
  year: 2022
  end-page: 673
  ident: CR59
  article-title: Is early-onset cancer an emerging global epidemic? Current evidence and future implications
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-022-00672-8
– volume: 6
  start-page: 31358
  year: 2016
  ident: CR41
  article-title: Hypertension and risk of prostate cancer: a systematic review and meta-analysis
  publication-title: Sci Rep
  doi: 10.1038/srep31358
– volume: 92
  start-page: 121
  year: 2019
  end-page: 135
  ident: CR3
  article-title: Obesity and cancer risk: emerging biological mechanisms and perspectives
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2018.11.001
– volume: 64
  start-page: 540
  year: 2021
  end-page: 551
  ident: CR27
  article-title: Association between diabetes and haematological malignancies: a population-based study
  publication-title: Diabetologia
  doi: 10.1007/s00125-020-05338-7
– volume: 97
  start-page: 230
  year: 2019
  end-page: 238
  ident: CR42
  article-title: Countdown to 2030: eliminating hepatitis B disease, China
  publication-title: Bull World Health Organ
  doi: 10.2471/BLT.18.219469
– volume: 18
  start-page: 230
  year: 2021
  end-page: 243
  ident: CR1
  article-title: Rising incidence of early-onset colorectal cancer—a call to action
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-020-00445-1
– volume: 68
  start-page: 31
  year: 2018
  end-page: 54
  ident: CR34
  article-title: Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21440
– volume: 14
  start-page: 3277
  year: 2022
  ident: CR15
  article-title: Metabolic diseases and risk of head and neck cancer: a cohort study analyzing nationwide population-based data
  publication-title: Cancers
  doi: 10.3390/cancers14133277
– volume: 34
  start-page: 1626
  year: 2016
  end-page: 1633
  ident: CR12
  article-title: Cardiovascular disease risk profiles in survivors of adolescent and young adult (AYA) cancer: the kaiser permanente AYA cancer survivors study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2015.65.5845
– volume: 136
  start-page: E720
  year: 2015
  end-page: 730
  ident: CR52
  article-title: Total, caffeinated and decaffeinated coffee and tea intake and gastric cancer risk: results from the EPIC cohort study
  publication-title: Intl J Cancer
  doi: 10.1002/ijc.29223
– volume: 15
  start-page: e493
  year: 2014
  end-page: e503
  ident: CR20
  article-title: Cancer-related inflammation and treatment effectiveness
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(14)70263-3
– volume: 537
  start-page: S103
  year: 2016
  end-page: S104
  ident: CR24
  article-title: Alcohol: fortifying spirits
  publication-title: Nature
  doi: 10.1038/537S103a
– volume: 39
  start-page: 477
  year: 2015
  end-page: 484
  ident: CR61
  article-title: Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions
  publication-title: Aust New Zealand J Public Health
  doi: 10.1111/1753-6405.12471
– volume: 125
  start-page: 2212
  year: 2012
  end-page: 2221
  ident: CR64
  article-title: Serum lipids and lipoproteins in Chinese men and women
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.065904
– volume: 65
  start-page: 2205
  year: 2022
  end-page: 2217
  ident: CR26
  article-title: A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer
  publication-title: Sci China Life Sci
  doi: 10.1007/s11427-022-2104-3
– volume: 128
  start-page: 299
  year: 2022
  end-page: 310
  ident: CR53
  article-title: Trends in the incidence of early-onset colorectal cancer in all 50 United States from 2001 through 2017
  publication-title: Cancer
  doi: 10.1002/cncr.33916
– volume: 21
  start-page: 1165
  year: 2020
  end-page: 1172
  ident: CR23
  article-title: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(20)30398-3
– volume: 34
  start-page: 753
  year: 2019
  end-page: 763
  ident: CR40
  article-title: Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults
  publication-title: Eur J Epidemiol
  doi: 10.1007/s10654-019-00530-5
– volume: 29
  start-page: 1592
  year: 2011
  end-page: 1598
  ident: CR36
  article-title: Total cholesterol and cancer risk in a large prospective study in Korea
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2010.31.5200
– volume: 73
  start-page: 17
  year: 2023
  end-page: 48
  ident: CR55
  article-title: Cancer statistics, 2023
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21763
– volume: 10
  start-page: 975
  year: 2020
  end-page: 986
  ident: CR39
  article-title: The association and joint effect of serum cholesterol, glycemic status with the risk of incident cancer among middle-aged and elderly population in china cardiometabolic disease and cancer cohort (4C)-study
  publication-title: Am J Cancer Res
– volume: 420
  start-page: 860
  year: 2002
  end-page: 867
  ident: CR17
  article-title: Inflammation and cancer
  publication-title: Nature
  doi: 10.1038/nature01322
– volume: 17
  start-page: 119
  year: 2018
  ident: CR45
  article-title: Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-018-0768-7
– volume: 18
  start-page: 1579
  year: 2017
  end-page: 1589
  ident: CR25
  article-title: Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(17)30677-0
– volume: 5
  start-page: 637
  year: 2013
  end-page: 645
  ident: CR62
  article-title: 27-hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2013.10.006
– volume: 52
  start-page: 89
  year: 2016
  end-page: 98
  ident: CR50
  article-title: Hypertension, serum lipids and cancer risk: a review of epidemiological evidence
  publication-title: Medicina
  doi: 10.1016/j.medici.2016.03.002
– volume: 9
  start-page: e95197
  year: 2014
  ident: CR2
  article-title: Rotavirus increases levels of lipidated LC3 supporting accumulation of infectious progeny virus without inducing autophagosome formation
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0095197
– volume: 71
  start-page: 899
  year: 2022
  end-page: 909
  ident: CR43
  article-title: The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer
  publication-title: Inflamm Res
  doi: 10.1007/s00011-022-01597-9
– volume: 118
  start-page: 1130
  year: 2018
  end-page: 1141
  ident: CR8
  article-title: The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015
  publication-title: Br J Cancer
  doi: 10.1038/s41416-018-0029-6
– volume: 95
  start-page: 1288
  year: 2006
  end-page: 1290
  ident: CR10
  article-title: Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6603386
– volume: 13
  start-page: 538
  year: 2023
  end-page: 551
  ident: CR5
  article-title: Early-onset cancer in the gastrointestinal tract is on the rise —evidence and implications
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-22-1038
– volume: 26
  start-page: 7061
  year: 2020
  ident: 2523_CR33
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v26.i44.7061
– volume: 21
  start-page: 5167
  year: 2015
  ident: 2523_CR35
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v21.i17.5167
– volume: 29
  start-page: 1592
  year: 2011
  ident: 2523_CR36
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2010.31.5200
– volume: 118
  start-page: 1130
  year: 2018
  ident: 2523_CR8
  publication-title: Br J Cancer
  doi: 10.1038/s41416-018-0029-6
– volume: 9
  start-page: 219
  year: 2019
  ident: 2523_CR21
  publication-title: Am J Cancer Res
– volume: 65
  start-page: 2205
  year: 2022
  ident: 2523_CR26
  publication-title: Sci China Life Sci
  doi: 10.1007/s11427-022-2104-3
– volume: 17
  start-page: 102896
  year: 2023
  ident: 2523_CR44
  publication-title: Diabetes Metab Syndr
  doi: 10.1016/j.dsx.2023.102896
– volume: 128
  start-page: 299
  year: 2022
  ident: 2523_CR53
  publication-title: Cancer
  doi: 10.1002/cncr.33916
– volume: 14
  start-page: 4021
  year: 2022
  ident: 2523_CR30
  publication-title: Cancers
  doi: 10.3390/cancers14164021
– volume: 248
  start-page: 2
  year: 2016
  ident: 2523_CR47
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2016.02.006
– volume: 41
  start-page: 1037
  year: 2021
  ident: 2523_CR49
  publication-title: Cancer Commun
  doi: 10.1002/cac2.12197
– volume: 7
  start-page: e1014
  year: 2022
  ident: 2523_CR11
  publication-title: Lancet Public Health
  doi: 10.1016/S2468-2667(22)00227-4
– volume: 17
  start-page: 119
  year: 2018
  ident: 2523_CR45
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-018-0768-7
– volume: 12
  start-page: 751
  year: 2012
  ident: 2523_CR48
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2012.07.006
– volume: 95
  start-page: 1288
  year: 2006
  ident: 2523_CR10
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6603386
– volume: 392
  start-page: 1923
  year: 2018
  ident: 2523_CR16
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)32225-6
– volume: 14
  start-page: 3277
  year: 2022
  ident: 2523_CR15
  publication-title: Cancers
  doi: 10.3390/cancers14133277
– volume: 8
  start-page: e1027
  year: 2020
  ident: 2523_CR32
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(20)30215-1
– volume: 64
  start-page: 540
  year: 2021
  ident: 2523_CR27
  publication-title: Diabetologia
  doi: 10.1007/s00125-020-05338-7
– volume: 4
  start-page: e137
  year: 2019
  ident: 2523_CR58
  publication-title: Lancet Public Health
  doi: 10.1016/S2468-2667(18)30267-6
– volume: 97
  start-page: 230
  year: 2019
  ident: 2523_CR42
  publication-title: Bull World Health Organ
  doi: 10.2471/BLT.18.219469
– volume: 42
  start-page: 820
  year: 2022
  ident: 2523_CR6
  publication-title: Liver Int
  doi: 10.1111/liv.15195
– volume: 67
  start-page: 122
  year: 2024
  ident: 2523_CR31
  publication-title: Sci China Life Sci
  doi: 10.1007/s11427-023-2423-1
– volume: 34
  start-page: 1626
  year: 2016
  ident: 2523_CR12
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2015.65.5845
– volume: 67
  start-page: 19
  year: 2024
  ident: 2523_CR9
  publication-title: Sci China Life Sci
  doi: 10.1007/s11427-022-2340-4
– volume: 66
  start-page: 2805
  year: 2023
  ident: 2523_CR13
  publication-title: Sci China Life Sci
  doi: 10.1007/s11427-023-2343-y
– volume: 39
  start-page: 477
  year: 2015
  ident: 2523_CR61
  publication-title: Aust New Zealand J Public Health
  doi: 10.1111/1753-6405.12471
– volume: 6
  start-page: 31358
  year: 2016
  ident: 2523_CR41
  publication-title: Sci Rep
  doi: 10.1038/srep31358
– volume: 15
  start-page: e493
  year: 2014
  ident: 2523_CR20
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(14)70263-3
– volume: 71
  start-page: 899
  year: 2022
  ident: 2523_CR43
  publication-title: Inflamm Res
  doi: 10.1007/s00011-022-01597-9
– volume: 5
  start-page: 125
  year: 2016
  ident: 2523_CR51
  publication-title: Eur Thyroid J
  doi: 10.1159/000445054
– volume: 5
  start-page: 637
  year: 2013
  ident: 2523_CR62
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2013.10.006
– volume: 13
  start-page: 790
  year: 2012
  ident: 2523_CR7
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(12)70211-5
– volume: 24
  start-page: 67
  year: 2015
  ident: 2523_CR60
  publication-title: Surg Oncol
  doi: 10.1016/j.suronc.2015.02.002
– volume: 19
  start-page: 18
  year: 2010
  ident: 2523_CR19
  publication-title: Eur J Cancer Prev
  doi: 10.1097/CEJ.0b013e328330eb1a
– volume: 68
  start-page: 31
  year: 2018
  ident: 2523_CR34
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21440
– volume: 537
  start-page: S103
  year: 2016
  ident: 2523_CR24
  publication-title: Nature
  doi: 10.1038/537S103a
– volume: 92
  start-page: 121
  year: 2019
  ident: 2523_CR3
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2018.11.001
– volume: 68
  start-page: 2179
  year: 2019
  ident: 2523_CR56
  publication-title: Gut
  doi: 10.1136/gutjnl-2019-319511
– volume: 69
  start-page: 300
  year: 2016
  ident: 2523_CR22
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2015.08.037
– volume: 13
  start-page: 538
  year: 2023
  ident: 2523_CR5
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-22-1038
– volume: 1
  start-page: e1109
  year: 2018
  ident: 2523_CR4
  publication-title: Cancer Rep
  doi: 10.1002/cnr2.1109
– volume: 34
  start-page: 4197
  year: 2016
  ident: 2523_CR28
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2016.70.5327
– ident: 2523_CR54
  doi: 10.1093/jnci/djw322
– volume: 10
  start-page: 975
  year: 2020
  ident: 2523_CR39
  publication-title: Am J Cancer Res
– volume: 66
  start-page: 115
  year: 2016
  ident: 2523_CR14
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21338
– volume: 21
  start-page: 1165
  year: 2020
  ident: 2523_CR23
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(20)30398-3
– volume: 112
  start-page: 1105
  year: 2020
  ident: 2523_CR29
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djaa007
– volume: 34
  start-page: 753
  year: 2019
  ident: 2523_CR40
  publication-title: Eur J Epidemiol
  doi: 10.1007/s10654-019-00530-5
– volume: 73
  start-page: 17
  year: 2023
  ident: 2523_CR55
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21763
– volume: 96
  start-page: 1056
  year: 2012
  ident: 2523_CR46
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.111.031419
– volume: 9
  start-page: e95197
  year: 2014
  ident: 2523_CR2
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0095197
– volume: 420
  start-page: 860
  year: 2002
  ident: 2523_CR17
  publication-title: Nature
  doi: 10.1038/nature01322
– volume: 52
  start-page: 89
  year: 2016
  ident: 2523_CR50
  publication-title: Medicina
  doi: 10.1016/j.medici.2016.03.002
– volume: 67
  start-page: 274
  year: 2024
  ident: 2523_CR63
  publication-title: Sci China Life Sci
  doi: 10.1007/s11427-023-2422-x
– volume: 99
  start-page: 801
  year: 2007
  ident: 2523_CR37
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djk181
– volume: 125
  start-page: 2212
  year: 2012
  ident: 2523_CR64
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.065904
– volume: 366
  start-page: 1784
  year: 2005
  ident: 2523_CR18
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67725-2
– volume: 19
  start-page: 656
  year: 2022
  ident: 2523_CR59
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-022-00672-8
– volume: 18
  start-page: 230
  year: 2021
  ident: 2523_CR1
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-020-00445-1
– volume: 122
  start-page: 116
  year: 2016
  ident: 2523_CR38
  publication-title: Cancer
  doi: 10.1002/cncr.29685
– volume: 18
  start-page: 1579
  year: 2017
  ident: 2523_CR25
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(17)30677-0
– volume: 32
  start-page: 129
  year: 2020
  ident: 2523_CR57
  publication-title: Chin J Cancer Res
  doi: 10.21147/j.issn.1000-9604.2020.02.01
– volume: 136
  start-page: E720
  year: 2015
  ident: 2523_CR52
  publication-title: Intl J Cancer
  doi: 10.1002/ijc.29223
SSID ssj0000330277
Score 2.3788908
Snippet The characteristics of early-onset (onset age <50 years) and later-onset (onset age ≽ 50 years) cancers differ significantly. Identifying novel risk factors...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1928
SubjectTerms Adult
Age
Age of Onset
Aged
Alcohol Drinking - adverse effects
Alcohol Drinking - epidemiology
Alcohol use
Biomedical and Life Sciences
Cancer
Case-Control Studies
China - epidemiology
Diabetes mellitus
Fatty liver
Female
Humans
Hypertension
Incidence
Inflammation
Life Sciences
Lipid metabolism
Liver cancer
Liver diseases
Male
Malignancy
Middle Aged
Neoplasms - epidemiology
Neoplasms - prevention & control
Population studies
Prospective Studies
Research Paper
Risk Factors
Smoking
Trends
Title Early-onset and later-onset cancer: trends, risk factors, and prevention in Northern China
URI https://link.springer.com/article/10.1007/s11427-023-2523-5
https://www.ncbi.nlm.nih.gov/pubmed/38809499
https://www.proquest.com/docview/3097828666
https://www.proquest.com/docview/3061784408
Volume 67
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEB60IngR30arrOBJu5Bms3l4K2ItHjxZKF5C9hEQyra06cF_787mUaQqeAl5TDZhZjc7m5n5PoBbKUShpVYUyzJpqFhKbb9RtB-pPJUilql2CbKv0Wgcvkz4pK7jXjbZ7k1I0n2p18Vu_TCIqZ1jaGBXT5Rvww6iiWEeV-g_tz9WfIahOEeqEmGuoe3QTTTzp1a-z0cbTuZGgNTNO8MD2K8dRjKoLHwIW9ocwW5FIfl5DO8OoZhiTnRJcqPI1DqPi_pYokkXD6R0ia89gnnkpGbY6TnpeY3gNDPkwxAXxNELQxyr9gmMh09vjyNa8yVQyeKgpLLw_UL5Cl2OvAhkLhPkUQrSWKkw5EowzuyOwDJyoRKfF4myHl_CeSSkPcVOoWNmRp8DKRCzJ2GJVSYCyPlpzFPVF8qub5iKROqB32gtkzWYOHJaTLM1DDIqOrOKzlDRGffgrr1lXiFp_CXcbUyR1YNqmTGsOQkSu-Dy4Ka9bIcDxjhyo2crlMGaR6TR9uCsMmH7NMS9QSweD-4bm64b__VVLv4lfQl7gXV7qiy0LnTKxUpfWbelFNeum9rtOBh8AbmJ4P0
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEB60InoR30arruBJu5Bms3l4K2KpWntqoXgJ2d0EhJKWND34793ZJC1SFbzlsXkws5v9NjPzfQC3Uog0kYmiWJZJXcVCqvuNom1PxaEUvgwTkyA78Hoj92XMx1Ud97zOdq9DkuZLvSp2a7uOT_UcQx29eqJ8E7Y0Fggwj2vkdJY_VmyGoTgjquJhrqHu0HU086e7fJ-P1kDmWoDUzDvdfdirACPplB4-gI0kO4TtUkLy8wjeDUMxxZzogsSZIhMNHvNqX6JL8wdSmMTXFsE8clIp7LRM61nF4DTNyEdGTBAnyTNiVLWPYdR9Gj72aKWXQCXznYLK1LZTZSuEHHHqyFgGqKPkhL5SrsuVYJzpDYFl5EIFNk8DpRFfwLknpD7ETqCRTbPkDEiKnD0BC7QxkUDODn0eqrZQen3DlCdCC-zaapGsyMRR02ISrWiQ0dCRNnSEho64BXfLS2Ylk8ZfjZu1K6JqUM0jhjUnTqAXXBbcLE_r4YAxjjhLpgtsgzWPKKNtwWnpwuXTkPcGuXgsuK99urr5r69y_q_W17DTG771o_7z4PUCdh0NgcqMtCY0inyRXGoIU4gr02W_AFxZ4zM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8QwEB50RfFFvK1nBJ_UsG3T9PBN1GU9WHxwQXwpTdKCINll7T74782kxyIe4FuP6cHMpJl0Zr4P4EQKUeQyVxTbMmmgWEKN3yjqhSpLpIhkktsC2UHYHwZ3z_y55jl9b6rdm5Rk1dOAKE267I5V0Z01vnmBH1Ez31DfrKQon4cF8zX20K2H_mX7k8VlmJazBCsh1h0a524ymz_d5evc9C3g_JYstXNQbxVW6uCRXFbWXoO5XK_DYkUn-bEBLxatmGJ9dEkyrcibCSQn9b5E804uSGmLYM8J1pSTmm3n3EqPazSnkSavmtiETj7RxDJsb8Kwd_N01ac1dwKVLPJLKgvXLZSrMPzICl9mMkZOJT-JlAoCrgTjzGwIbCkXKnZ5ESsT_cWch0KaQ2wLOnqk8x0gBeL3xCw2ykQwOTeJeKI8ocxah6lQJA64jdZSWQOLI7_FWzqDREZFp0bRKSo65Q6ctpeMK1SNv4T3G1Ok9QB7Txn2n_ixWXw5cNyeNkMD8x2ZzkdTlMH-R6TUdmC7MmH7NMTAQVweB84am85u_uur7P5L-giWHq976cPt4H4Pln0TDVXFafvQKSfT_MBEM6U4tB77CcFH528
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Early-onset+and+later-onset+cancer%3A+trends%2C+risk+factors%2C+and+prevention+in+Northern+China&rft.jtitle=Science+China.+Life+sciences&rft.au=Liu%2C+Tong&rft.au=Liu%2C+Chen-An&rft.au=Zhang%2C+Qing-Song&rft.au=Zhang%2C+Qi&rft.date=2024-09-01&rft.pub=Science+China+Press&rft.issn=1674-7305&rft.eissn=1869-1889&rft.volume=67&rft.issue=9&rft.spage=1928&rft.epage=1940&rft_id=info:doi/10.1007%2Fs11427-023-2523-5&rft.externalDocID=10_1007_s11427_023_2523_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1674-7305&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1674-7305&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1674-7305&client=summon